EASL survey on the impact of COVID-19 on viral hepatitis elimination

1.Personnal information(Required.)

Name of your centre

Email address

City/Town

Country

Number of people, in the local geographical population, served by your centre (for any health matters):

2.Please provide your answer to these questions as a number, indicating a total (for 2019 and for 2020)(Required.)

1. Number of total outpatient hepatitis B consultations for 2019?

and for 2020:

1.1 How many of these consultations were new referrals for 2019?

and for 2020:

2. Number of total outpatient hepatitis C consultations for 2019?

and for 2020:

2.1. How many of these consultations were new referrals for 2019?

and for 2020:

3. Number of hepatitis B surface antigen (HBsAg) tests carried out for 2019?

and for 2020:

3.1 How many of these tests gave positive results for 2019?

and for 2020:

4. Number of HBV DNA tests performed for 2019?

and for 2020:

4.1 In how many cases was HBV DNA detectable for 2019?

and for 2020:

5. Number of HCV RNA tests performed for 2019?

and for 2020:

5.1 In how many cases was HCV RNA detectable for 2019?

and for 2020:

6. Number of patients who started treatment for HCV for 2019?

and for 2020:

7. Number of patients who started treatment for HBV for 2019?

and for 2020:

3.Is your centre part of a hospital also treating COVID-19 patients?(Required.)

Yes

You have questions, please feel free to email us at yoanna.nedelcheva@easloffice.eu

Survey